Beta Drugs Limited (NSE:BETA)

India flag India · Delayed Price · Currency is INR
1,098.00
+30.20 (2.83%)
At close: Mar 6, 2026
-35.16%
Market Cap 11.08B
Revenue (ttm) 3.85B
Net Income (ttm) 414.68M
Shares Out 10.09M
EPS (ttm) 39.54
PE Ratio 27.77
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,137
Average Volume 19,234
Open 1,051.80
Previous Close 1,067.80
Day's Range 1,051.80 - 1,108.10
52-Week Range 990.10 - 2,000.00
Beta -0.50
RSI 33.05
Earnings Date Feb 12, 2026

About Beta Drugs

Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI). The company exports its products. Beta Drugs Limited was founded in 1985 and is based in Panchkula, India. [Read more]

Sector Healthcare
Founded 1985
Employees 399
Stock Exchange National Stock Exchange of India
Ticker Symbol BETA
Full Company Profile

Financial Performance

In fiscal year 2025, Beta Drugs's revenue was 3.62 billion, an increase of 22.54% compared to the previous year's 2.96 billion. Earnings were 424.19 million, an increase of 16.42%.

Financial Statements

News

There is no news available yet.